XD2-149

CAT: 0804-HY-159570Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-159570Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
XD2-149 is a PROTAC targeting STAT3. XD2-149 consists of PROTAC target protein ligand Napabucasin (HY-13919) (red part), E3 ligase Thalidomide (HY-14658) (black part), and linker NH2-C5-Azacyclohexane-N-Boc (HY-159572) (blue part) . The E3 ligase + linker conjugate is Thalidomide-NH-C5-azacyclohexane-N-Boc (HY-159571), and the active control of the target protein ligand is Thalidomide acid (HY-159573) [1].
CAS Number
[2710221-08-0]
UNSPSC
12352005
Target
PROTACs; STAT
Type
Reference compound
Related Pathways
JAK/STAT Signaling; PROTAC; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/xd2-149.html
Smiles
O=C(C1=CC2=C(C(C3=C(C2=O)C=CC=C3)=O)O1)NCCN4CCC(CCCCCNC5=CC=CC(C(N6C7C(NC(CC7)=O)=O)=O)=C5C6=O)CC4
Molecular Formula
C38H39N5O8
Molecular Weight
693.74
References & Citations
[1]Hanafi M, et al. Discovery of a Napabucasin PROTAC as an Effective Degrader of the E3 Ligase ZFP91. J Med Chem. 2021 Feb 11;64 (3) :1626-1648.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-145341-01GNE-149
HY-169214AV22-149
HY-15887-01MG 149
HY-117348-01NCC-149
HY-168471AAL-149
HY-169570EGFR-IN-149
HY-W675573VF-149
HY-161425Antitumor agent-149
HY-155096Antibacterial agent 149
HY-N11919-01Anticancer agent 149

Alternative Products

CatalogName
T200304-01XD2-149
sc-152300-PRPLC-XD2 (m) -PR
sc-78111-PRPLC-XD2 (h) -PR
sc-78111PLC-XD2 siRNA (h)
sc-152300PLC-XD2 siRNA (m)
sc-152300-SHPLC-XD2 shRNA Plasmid (m)
sc-417114-HDRPLC-XD2 HDR Plasmid (h)
sc-436618-HDRPLC-XD2 HDR Plasmid (m)
sc-78111-SHPLC-XD2 shRNA Plasmid (h)
sc-417114-NIC-2PLC-XD2 Double Nickase Plasmid (h2)

Popular Products